{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:58:40Z","timestamp":1786118320597,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ANPCyT PICT 2021-GRF-TI-00561"],"award-info":[{"award-number":["ANPCyT PICT 2021-GRF-TI-00561"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ANPCyT PICT 2019-282"],"award-info":[{"award-number":["ANPCyT PICT 2019-282"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012478","name":"Secretaria de Ciencia y Tecnolog\u00eda - Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","award":["PIDTA-SECYT 2023\u20132027"],"award-info":[{"award-number":["PIDTA-SECYT 2023\u20132027"]}],"id":[{"id":"10.13039\/100012478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2022\u20132024"],"award-info":[{"award-number":["PIP 2022\u20132024"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2020-2022"],"award-info":[{"award-number":["PIP 2020-2022"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","award":["AARGD-22-926476"],"award-info":[{"award-number":["AARGD-22-926476"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06116-z","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:47:34Z","timestamp":1786031254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gallein-Loaded Albumin Nanoparticles Prevent Amyloid-\u03b2\u2013Induced Amyloidogenic APP Processing, Synaptic Loss, and Dendritic Pathology"],"prefix":"10.1007","volume":"63","author":[{"given":"Romina Soledad","family":"Almir\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Antonino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Marmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Debiagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina","family":"Toselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Allemandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Alejandra","family":"Quinteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Anahi","family":"Bignante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"6116_CR1","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.neurobiolaging.2013.04.021","volume":"34","author":"EA Bignante","year":"2013","unstructured":"Bignante EA, Heredia F, Morfini G, Lorenzo A (2013) Amyloid \u03b2 precursor protein as a molecular target for amyloid \u03b2\u2013induced neuronal degeneration in Alzheimer\u2019s disease. Neurobiol Aging 34:2525\u20132537. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.04.021","journal-title":"Neurobiol Aging"},{"key":"6116_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"6116_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE et al (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement 7:367\u2013385. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351","journal-title":"Alzheimers Dement"},{"key":"6116_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T et al (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537:50\u201356. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"key":"6116_CR5","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1002\/alz.13836","volume":"20","author":"R Kalaria","year":"2024","unstructured":"Kalaria R, Maestre G, Mahinrad S et al (2024) The 2022 symposium on dementia and brain aging in low- and middle-income countries: highlights on research, diagnosis, care, and impact. Alzheimers Dement 20:4290\u20134314. https:\/\/doi.org\/10.1002\/alz.13836","journal-title":"Alzheimers Dement"},{"key":"6116_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neurobiolaging.2017.12.013","volume":"64","author":"EA Bignante","year":"2018","unstructured":"Bignante EA, Ponce NE, Heredia F et al (2018) APP\/Go protein G\u03b2\u03b3-complex signaling mediates A\u03b2 degeneration and cognitive impairment in Alzheimer\u2019s disease models. Neurobiol Aging 64:44\u201357. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.12.013","journal-title":"Neurobiol Aging"},{"key":"6116_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.852738","volume":"10","author":"M Antonino","year":"2022","unstructured":"Antonino M, Marmo P, Freites CL et al (2022) A\u03b2 assemblies promote amyloidogenic processing of APP and intracellular accumulation of A\u03b242 through Go\/G\u03b2\u03b3 signaling. Front Cell Dev Biol 10:852738. https:\/\/doi.org\/10.3389\/fcell.2022.852738","journal-title":"Front Cell Dev Biol"},{"key":"6116_CR8","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.jacc.2014.02.587","volume":"63","author":"FA Kamal","year":"2014","unstructured":"Kamal FA, Mickelsen DM, Wegman KM et al (2014) Simultaneous adrenal and cardiac G-protein\u2013coupled receptor-G\u03b2\u03b3 inhibition halts heart failure progression. J Am Coll Cardiol 63:2549\u20132557. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.587","journal-title":"J Am Coll Cardiol"},{"key":"6116_CR9","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/art.39673","volume":"68","author":"J Rangel\u2010Moreno","year":"2016","unstructured":"Rangel\u2010Moreno J, To JY, Owen T et al (2016) Inhibition of G protein \u03b2\u03b3 subunit signaling abrogates nephritis in lupus\u2010prone mice. Arthritis Rheumatol 68:2244\u20132256. https:\/\/doi.org\/10.1002\/art.39673","journal-title":"Arthritis Rheumatol"},{"key":"6116_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-017-2879-z","volume":"10","author":"G Sanz","year":"2017","unstructured":"Sanz G, Leray I, Muscat A et al (2017) Gallein, a G\u03b2\u03b3 subunit signalling inhibitor, inhibits metastatic spread of tumour cells expressing OR51E2 and exposed to its odorant ligand. BMC Res Notes 10:541. https:\/\/doi.org\/10.1186\/s13104-017-2879-z","journal-title":"BMC Res Notes"},{"key":"6116_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1043581","volume":"14","author":"J Danaf","year":"2023","unstructured":"Danaf J, da Silveira Scarpellini C, Montandon G (2023) \u03b2\u03b3 G-proteins, but not regulators of G-protein signaling 4, modulate opioid-induced respiratory rate depression. Front Physiol 14:1043581. https:\/\/doi.org\/10.3389\/fphys.2023.1043581","journal-title":"Front Physiol"},{"key":"6116_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167725","volume":"26","author":"J Koga-Batko","year":"2025","unstructured":"Koga-Batko J, Antosz-Popio\u0142ek K, Nowakowska H et al (2025) Nanoparticles as an encouraging therapeutic approach to Alzheimer\u2019s disease. Int J Mol Sci 26:7725. https:\/\/doi.org\/10.3390\/ijms26167725","journal-title":"Int J Mol Sci"},{"key":"6116_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/13872877251374149","volume":"107","author":"G Liu","year":"2025","unstructured":"Liu G, Sun Y (2025) Harnessing nanoparticles for Alzheimer\u2019s disease: innovations in drug delivery and pathology-specific treatments. J Alzheimers Dis 107:1374\u20131399. https:\/\/doi.org\/10.1177\/13872877251374149","journal-title":"J Alzheimers Dis"},{"key":"6116_CR14","doi-asserted-by":"publisher","unstructured":"Mishra D, Yadav S (2025) Emerging nanoparticle drug delivery approaches for the treatment of Alzheimer\u2019s disease: a review. Int J Newgen Res Pharm Healthc 216\u2013225. https:\/\/doi.org\/10.61554\/ijnrph.v3i1.2025.171","DOI":"10.61554\/ijnrph.v3i1.2025.171"},{"key":"6116_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119289","volume":"581","author":"AL Mart\u00ednez-L\u00f3pez","year":"2020","unstructured":"Mart\u00ednez-L\u00f3pez AL, Pangua C, Reboredo C et al (2020) Protein-based nanoparticles for drug delivery purposes. Int J Pharm 581:119289. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119289","journal-title":"Int J Pharm"},{"key":"6116_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.629520","volume":"7","author":"H Xie","year":"2021","unstructured":"Xie H, Guo C (2021) Albumin alters the conformational ensemble of amyloid-\u03b2 by promiscuous interactions: implications for amyloid inhibition. Front Mol Biosci 7:629520. https:\/\/doi.org\/10.3389\/fmolb.2020.629520","journal-title":"Front Mol Biosci"},{"key":"6116_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41565-021-00897-1","volume":"16","author":"R Li","year":"2021","unstructured":"Li R, Ng TSC, Wang SJ et al (2021) Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer. Nat Nanotechnol 16:830\u2013839. https:\/\/doi.org\/10.1038\/s41565-021-00897-1","journal-title":"Nat Nanotechnol"},{"key":"6116_CR18","unstructured":"Fontecha E, Regnault M (2016) Validation of analytical method for the determination of N-Acetyl-DL-tryptophan in albumin samples by High Performance Liquid Chromatography. Rev Fac Farm 79:87\u201396"},{"key":"6116_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124161","volume":"1240","author":"A Inda","year":"2024","unstructured":"Inda A, Tettamanti CS, Martinez SM et al (2024) New RP-HPLC method for the simultaneous determination of process yield and percentage of encapsulation of Gallein in albumin nanoparticles. J Chromatogr B 1240:124161. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124161","journal-title":"J Chromatogr B"},{"key":"6116_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122308","volume":"628","author":"S Mickaela Martinez","year":"2022","unstructured":"Mickaela Martinez S, Inda A, Marina Garcia A et al (2022) Development of melatonin-loaded, human-serum-albumin nanoparticles formulations using different methods of preparation for ophthalmic administration. Int J Pharm 628:122308. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122308","journal-title":"Int J Pharm"},{"key":"6116_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2025.139374","volume":"734","author":"A Inda","year":"2026","unstructured":"Inda A, Bessone CDV, Aloisio C et al (2026) Carvacrol-loaded liquid crystalline nanoparticles based on phytantriol and Peceol\u00ae: a novel nanoplatform for controlled drug delivery and synthetic luminescence. Colloids Surf Physicochem Eng Asp 734:139374. https:\/\/doi.org\/10.1016\/j.colsurfa.2025.139374","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"6116_CR22","doi-asserted-by":"crossref","unstructured":"Stine WB, Jungbauer L, Yu C, LaDu MJ (2010) Preparing synthetic A\u03b2 in different aggregation states. In: Roberson ED (ed) Alzheimer\u2019s disease and frontotemporal dementia. Humana Press, Totowa, NJ, pp 13\u201332","DOI":"10.1007\/978-1-60761-744-0_2"},{"key":"6116_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nn.4188","volume":"19","author":"U Das","year":"2016","unstructured":"Das U, Wang L, Ganguly A et al (2016) Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19:55\u201364. https:\/\/doi.org\/10.1038\/nn.4188","journal-title":"Nat Neurosci"},{"key":"6116_CR24","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK et al (2002) An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered \u03b1-synuclein metabolism and oxidative damage. J Neurosci 22:7006\u20137015. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-16-07006.2002","journal-title":"J Neurosci"},{"key":"6116_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.scr.2015.12.026","volume":"16","author":"M Questa","year":"2016","unstructured":"Questa M, Romorini L, Bl\u00fcguermann C et al (2016) Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts. Stem Cell Res 16:300\u2013303. https:\/\/doi.org\/10.1016\/j.scr.2015.12.026","journal-title":"Stem Cell Res"},{"key":"6116_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrd.2018.135","volume":"17","author":"AP Campbell","year":"2018","unstructured":"Campbell AP, Smrcka AV (2018) Targeting G protein-coupled receptor signalling by blocking G proteins. Nat Rev Drug Discov 17:789\u2013803. https:\/\/doi.org\/10.1038\/nrd.2018.135","journal-title":"Nat Rev Drug Discov"},{"key":"6116_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2144\/btn-2020-0152","volume":"70","author":"SE Honeycutt","year":"2021","unstructured":"Honeycutt SE, O\u2019Brien LL (2021) Injection of Evans blue dye to fluorescently label and image intact vasculature. Biotechniques 70:181\u2013185. https:\/\/doi.org\/10.2144\/btn-2020-0152","journal-title":"Biotechniques"},{"key":"6116_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.573987","volume":"8","author":"MC Paz","year":"2020","unstructured":"Paz MC, Barcelona PF, Subirada PV et al (2020) Metabolic syndrome triggered by fructose diet impairs neuronal function and vascular integrity in ApoE-KO mouse retinas: implications of autophagy deficient activation. Front Cell Dev Biol 8:573987. https:\/\/doi.org\/10.3389\/fcell.2020.573987","journal-title":"Front Cell Dev Biol"},{"key":"6116_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1326-6-63","volume":"6","author":"RM Koffie","year":"2011","unstructured":"Koffie RM, Hyman BT, Spires-Jones TL (2011) Alzheimer\u2019s disease: synapses gone cold. Mol Neurodegener 6:63. https:\/\/doi.org\/10.1186\/1750-1326-6-63","journal-title":"Mol Neurodegener"},{"key":"6116_CR30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L (2010) Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13:812\u2013818. https:\/\/doi.org\/10.1038\/nn.2583","journal-title":"Nat Neurosci"},{"key":"6116_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0306-4522(02)00241-5","volume":"114","author":"EA Grace","year":"2002","unstructured":"Grace EA, Rabiner CA, Busciglio J (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid \u03b2: implications for Alzheimer\u2019s disease. Neuroscience 114:265\u2013273. https:\/\/doi.org\/10.1016\/S0306-4522(02)00241-5","journal-title":"Neuroscience"},{"key":"6116_CR32","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","volume":"30","author":"H-Y Wu","year":"2010","unstructured":"Wu H-Y, Hudry E, Hashimoto T et al (2010) Amyloid \u03b2 induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci 30:2636\u20132649. https:\/\/doi.org\/10.1523\/JNEUROSCI.4456-09.2010","journal-title":"J Neurosci"},{"key":"6116_CR33","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA et al (1998) Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448\u20136453. https:\/\/doi.org\/10.1073\/pnas.95.11.6448","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6116_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8:101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6116_CR35","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/alz.12137","volume":"16","author":"M Boada","year":"2020","unstructured":"Boada M, L\u00f3pez OL, Olazar\u00e1n J et al (2020) A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer\u2019s disease: primary results of the AMBAR study. Alzheimers Dement 16:1412\u20131425. https:\/\/doi.org\/10.1002\/alz.12137","journal-title":"Alzheimers Dement"},{"key":"6116_CR36","doi-asserted-by":"publisher","first-page":"71165","DOI":"10.1039\/C6RA14590F","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Cheng F, Xu L, Jia L (2016) HSA targets multiple A\u03b242 species and inhibits the seeding-mediated aggregation and cytotoxicity of A\u03b242 aggregates. RSC Adv 6:71165\u201371175. https:\/\/doi.org\/10.1039\/C6RA14590F","journal-title":"RSC Adv"},{"key":"6116_CR37","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1021\/acschemneuro.1c00150","volume":"12","author":"M Zhao","year":"2021","unstructured":"Zhao M, Guo C (2021) Multipronged regulatory functions of serum albumin in early stages of amyloid-\u03b2 aggregation. ACS Chem Neurosci 12:2409\u20132420. https:\/\/doi.org\/10.1021\/acschemneuro.1c00150","journal-title":"ACS Chem Neurosci"},{"key":"6116_CR38","doi-asserted-by":"publisher","unstructured":"Cora D, Al-Soufi W, Novo M (2025) Amyloid capture and aggregation inhibition by Human Serum Albumin.\u00a0Int J Biol Macromol 301:140367. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140367","DOI":"10.1016\/j.ijbiomac.2025.140367"},{"key":"6116_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.csbj.2019.06.017","volume":"17","author":"P Pic\u00f3n-Pag\u00e8s","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s P, Bonet J, Garc\u00eda-Garc\u00eda J et al (2019) Human albumin impairs amyloid \u03b2-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in Alzheimer\u2019s disease. Comput Struct Biotechnol J 17:963\u2013971. https:\/\/doi.org\/10.1016\/j.csbj.2019.06.017","journal-title":"Comput Struct Biotechnol J"},{"key":"6116_CR40","doi-asserted-by":"publisher","unstructured":"(2020) Computational investigation on the role of C-Terminal of human albumin on the dimerization of A\u03b21\u201342 peptide. Biointerface Res Appl Chem 10:4944\u20134955. https:\/\/doi.org\/10.33263\/BRIAC101.944955","DOI":"10.33263\/BRIAC101.944955"},{"key":"6116_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/pharmaceutics17010085","volume":"17","author":"SM Martinez","year":"2025","unstructured":"Martinez SM, Inda A, R\u00edos MN et al (2025) Neuroprotective effect of melatonin loaded in human serum albumin nanoparticles applied subconjunctivally in a retinal degeneration animal model. Pharmaceutics 17:85. https:\/\/doi.org\/10.3390\/pharmaceutics17010085","journal-title":"Pharmaceutics"},{"key":"6116_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102379","volume":"99","author":"D Shastri","year":"2024","unstructured":"Shastri D, Raj V, Lee S (2024) Revolutionizing Alzheimer\u2019s treatment: harnessing human serum albumin for targeted drug delivery and therapy advancements. Ageing Res Rev 99:102379. https:\/\/doi.org\/10.1016\/j.arr.2024.102379","journal-title":"Ageing Res Rev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06116-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:47:37Z","timestamp":1786031257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6116"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06116-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"816"}}